...
首页> 外文期刊>European journal of ophthalmology >Ophthalmologic abnormalities in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Presentation of a long-term survivor.
【24h】

Ophthalmologic abnormalities in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: Presentation of a long-term survivor.

机译:长链3-羟酰基-CoA脱氢酶缺乏症的眼科异常:长期幸存者的表现。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE. Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is one of the recently discovered defects of mitochondrial fatty acid beta-oxidation surprisingly associated with ophthalmologic abnormalities. The presentation of a long-term survivor may enlarge the clinical spectrum associated with this disorder. METHODS. A 12-year retrospective review of the clinical course of a 19-year-old long-term survivor was performed. The author concentrated on characteristic ophthalmologic measures: visual acuity, refraction, ophthalmoscopy, visual fields, and electroretinography. RESULTS. The author found a milder course than described in the literature, although very few case reports of long-term survivors have been published. The patient developed slower circumscribed atrophy of the choroid, retinal pigment epithelium, and retina. CONCLUSIONS. Because of therapeutic and prenatal diagnostic opportunities in LCHAD deficiency, it is important to recognize this severe disorder early in its course. This maylead to a milder course and better prognosis due to early dietary therapy.
机译:目的。长链3-羟酰基辅酶A脱氢酶(LCHAD)缺乏是最近发现的线粒体脂肪酸β-氧化的缺陷之一,令人惊讶地与眼科异常有关。长期幸存者的出现可能会扩大与此疾病相关的临床范围。方法。对一名19岁长期幸存者的临床病程进行了12年回顾性回顾。作者主要研究眼科特征性措施:视力,折射,检眼镜,视野和视网膜电图。结果。尽管已经发表了很少的关于长期幸存者的病例报告,但作者发现病程比文献中描述的要温和。该患者的脉络膜,视网膜色素上皮和视网膜的界限性萎缩较慢。结论。由于存在LCHAD缺乏症的治疗和产前诊断机会,因此必须在病程中及早识别出这种严重疾病。由于早期饮食疗法,这可能导致病程更轻,预后更好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号